Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

CRVS

Corvus Pharmaceuticals Inc

Jun 18 • 04:00PM ET

11.91

-0.09 -0.75 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: IDYA RCUS TNGX CGON KYMR NUVL BMRN RYTM INCY KRYS

| Held by: XBI VTI IWM VXF IWO IBB VTWO USVM VHT LFSC

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-0.53	Insider Own	24.87%	Shs Outstand	84.09M	Perf Week	2.67%
Market Cap	1.00B	Forward P/E	-	EPS next Y	-0.85	Insider Trans	0.14%	Shs Float	63.18M	Perf Month	3.57%
Enterprise Value	765.64M	PEG	-	EPS next Q	-0.16	Inst Own	63.27%	Short Float	27.42%	Perf Quarter	-15.47%
Income	-44.17M	P/S	-	EPS this Y	-258.33%	Inst Trans	40.09%	Short Ratio	11.65	Perf Half Y	50.00%
Sales	0.00M	P/B	4.16	EPS next Y	-25.46%	ROA	-28.26%	Short Interest	17.32M	Perf YTD	54.68%
Book/sh	2.86	P/C	4.23	EPS next 5Y	-	ROE	-30.46%	52W High	26.95 -55.81%	Perf Year	203.05%
Cash/sh	2.81	P/FCF	-	EPS past 3/5Y	15.40% -21.44%	ROIC	-18.32%	52W Low	3.55 235.49%	Perf 3Y	431.70%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	5.98% 6.15%	Perf 5Y	336.26%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	17.91%	Oper. Margin	-	ATR (14)	0.81	Perf 10Y	-3.87%
Dividend Ex-Date	-	Quick Ratio	19.81	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	43.51	Recom	1.14
Dividend Gr. 3/5Y	- -	Current Ratio	19.81	EPS Q/Q	-15.05%	SMA20	-0.39%	Beta	0.86	Target Price	33.33
Payout	-	Debt/Eq	0.00	Sales Q/Q	-	SMA50	-14.10%	Rel Volume	1.33	Prev Close	12.00
Employees	37	LT Debt/Eq	0.00	Earnings	May 07 AMC	SMA200	0.57%	Avg Volume	1.49M	Price	11.91
IPO	Mar 23, 2016	Option/Short	Yes / Yes	EPS/Sales Surpr.	-5.34% -	Trades		Volume	1,976,070	Change	-0.75%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)